Medicare Enrolled
Dr. Ram Lalchandani, M.D.
Hematology & Oncology · Carmichael, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lalchandani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lalchandani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lalchandani
Dr. Ram Lalchandani is a hematology & oncology specialist in Carmichael, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lalchandani performed 102,953 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lalchandani received a total of $5,830 from 41 pharmaceutical and/or device companies across 182 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lalchandani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in CA
$5,830 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗102,953
Medicare services
Top 7% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
40,800 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,000 | $0 | $3 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 13,650 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 8,400 | $43 | $127 |
| Paclitaxel chemotherapy injection | 6,592 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 4,808 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,672 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,495 | $8 | $22 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,120 | $6 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,088 | $7 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,038 | $103 | $287 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $70 | $198 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
540 | $2 | $4 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
514 | $113 | $369 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
498 | $13 | $44 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
476 | $25 | $83 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
371 | $10 | $30 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
359 | $2 | $7 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
267 | $6 | $28 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
266 | $19 | $63 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
251 | $11 | $38 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
249 | $52 | $179 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
196 | $17 | $56 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
188 | $56 | $179 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
169 | $24 | $81 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
150 | $1 | $3 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
148 | $11 | $39 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
117 | $0 | $6 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
109 | $2 | $6 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
108 | $145 | $377 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
88 | $29 | $83 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
72 | $66 | $189 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
64 | $40 | $102 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
63 | $1 | $4 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $135 | $426 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
51 | $88 | $281 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
49 | $1 | $1 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
46 | $77 | $269 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
34 | $1 | $3 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
33 | $29 | $92 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $144 | $527 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
11 | $85 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
41.5% high complexity
53.2% medium
5.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,830
Total received (2018-2024)
Avg $833/year across 7 years
Top 41% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
182
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,408
2023
$400
2022
$525
2021
$1,374
2020
$248
2019
$569
2018
$306
Payments by company (2024)
US Oncology Corporate, Inc.
$1,697
Novartis Pharmaceuticals Corporation
$104
PFIZER INC.
$94
Lilly USA, LLC
$84
Janssen Biotech, Inc.
$75
E.R. Squibb & Sons, L.L.C.
$56
GlaxoSmithKline, LLC.
$42
Daiichi Sankyo Inc.
$42
SERVIER PHARMACEUTICALS LLC
$42
Celgene Corporation
$33
SpringWorks Therapeutics, Inc.
$30
AstraZeneca Pharmaceuticals LP
$28
ACCORD HEALTHCARE, INC.
$23
Genmab U.S., Inc.
$23
Genentech USA, Inc.
$20
Gilead Sciences, Inc.
$15
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
US Oncology Corporate, Inc.
$1,697
PFIZER INC.
$704
Janssen Biotech, Inc.
$370
E.R. Squibb & Sons, L.L.C.
$309
Astellas Pharma US Inc
$294
Genentech USA, Inc.
$235
Lilly USA, LLC
$202
Kite Pharma, Inc.
$193
Amgen Inc.
$193
Seagen Inc.
$175
Pharmacyclics LLC, An AbbVie Company
$164
Novartis Pharmaceuticals Corporation
$162
Merck Sharp & Dohme Corporation
$136
Gilead Sciences, Inc.
$115
SERVIER PHARMACEUTICALS LLC
$86
Integra LifeSciences Corporation
$82
Celgene Corporation
$67
McKesson Specialty Care Distribution, LLC
$66
Acrotech Biopharma LLC
$52
GlaxoSmithKline, LLC.
$42
Daiichi Sankyo Inc.
$42
JAZZ PHARMACEUTICALS INC.
$32
SpringWorks Therapeutics, Inc.
$30
AstraZeneca Pharmaceuticals LP
$28
UIH Solutions LLC
$25
Otsuka America Pharmaceutical, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
ACCORD HEALTHCARE, INC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Deciphera Pharmaceuticals Inc.
$23
Genmab U.S., Inc.
$23
Myovant Sciences Inc.
$22
Ipsen Biopharmaceuticals, Inc
$21
Alexion Pharmaceuticals, Inc.
$21
ARRAY BIOPHARMA INC
$20
Janssen Pharmaceuticals, Inc
$20
SANOFI-AVENTIS U.S. LLC
$19
Jazz Pharmaceuticals Inc.
$18
APO-PHARMA USA, INC.
$17
Puma Biotechnology, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$13
Top 3 companies account for 47.5% of all-time payments
Associated products mentioned in payments ›
AFINITOR · Alecensa · Avastin · BELEODAQ · BOSULIF · BRAFTOVI · CAMCEVI · DARZALEX · DEFERIPRONE · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Epkinly · Erivedge · Erleada · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JEMPERLI · KEYTRUDA · Kadcyla · LIBTAYO · LUMAKRAS · LYNPARZA · NINLARO · Nerlynx · Nplate · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PLUVICTO · PROMACTA · Padcev · Pomalyst · Prolia · QINLOCK · REBLOZYL · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · TECENTRIQ · TENOGLIDE TENDON PROTECTOR SHEET · TIBSOVO · Tibsovo · Trodelvy · ULTOMIRIS · VERZENIO · VYNDAMAX · VYXEOS · XALKORI · XARELTO · XTANDI · Xospata · Yescarta · ZEPZELCA · uMR 570
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
82
County median income
$88,724
Nearest hospital to ZIP centroid (approximate)
MERCY SAN JUAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lalchandani is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lalchandani experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lalchandani performed 40,800 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lalchandani receive payments from pharmaceutical companies?
Yes. Dr. Lalchandani received a total of $5,830 from 41 companies across 182 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lalchandani's costs compare to other hematology & oncology specialists in Carmichael?
Dr. Lalchandani's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lalchandani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Carmichael
Browse hematology & oncology specialists in Carmichael ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology